Esperion believes in the need to support ethical independent research conducted by qualified third-party investigators. Such research must set out to address meaningful scientific and/or clinical hypotheses supported by valid study designs, in which the privacy rights, safety, and welfare of patients is the top priority.

Areas of interest:

Dyslipidemias

Statin intolerance

Atheroslcerotic cardiovascular disease (ASCVD)

Lipid-lowering therapies

Heterozygous familial hypercholesterolemia (HeFH)

Health economics and outcomes research (HEOR)

Real world evidence

Women in Cardology

For more information on the investigator initiated study objectives and application process, please review our program summary here.